Ontology highlight
ABSTRACT: Study objectives
The objective of this study was to test the hypothesis that use of zolpidem, eszopiclone, and zaleplon would be associated with increased risk of traumatic brain injury (TBI) and hip fracture.Methods
We conducted a case-crossover study on a 5% random sample of Medicare beneficiaries age 65 y or older hospitalized with either TBI (n = 15,031) or hip fracture (n = 37,833) during 2007-2009. Use of zolpidem, eszopiclone, or zaleplon during the 30-day period prior to injury hospitalization was compared to use during four control periods at 3, 6, 9, and 12 mo prior to injury. The primary outcome was hospitalization for TBI or hip fracture.Results
Zolpidem use during the month prior to injury was associated with increased risk of TBI (odds ratio [OR] 1.87;
SUBMITTER: Tom SE
PROVIDER: S-EPMC4835298 | biostudies-literature | 2016 May
REPOSITORIES: biostudies-literature